Zeynep Madak-Erdogan, University of Illinois at Urbana-Champaign (IMAGE)

University of Illinois at Urbana-Champaign, News Bureau

Zeynep Madak-Erdogan, University of Illinois at Urbana-Champaign

Caption

University of Illinois food science and human nutrition professor and her team found in a new study that targeting estrogen receptor-positive breast tumors with the XPO1 antagonist selinexor and the tamoxifen byproduct 4-OHT simultaneously rewires the cells' metabolism to overcome endocrine resistance.

Credit

Photo by Fred Zwicky

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.